 effect enalapril surviv patient reduc ventricular eject fraction congest heart failur solvd investig background patient congest heart failur high mortal rate effect angiotensin-converting-enzym inhibitor enalapril mortal hospit patient chronic heart failur eject fraction equal method patient convent treatment heart failur placebo dose mg day double-bind trial percent patient new york heart associ function class II iii follow-up month result death placebo group percent enalapril group percent reduct risk percent percent confid interv percent reduct mortal sever categori cardiac death reduct death heart failur placebo group enalapril group reduct risk percent percent confid interv percent littl appar effect treatment death due pump failur patient heart failur placebo group enalapril group risk reduct percent percent confid interv percent conclus addit enalapril convent therapi mortal hospit heart failur patient chronic congest heart failur reduc eject fraction